Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CHTR | CMCSA |
|---|---|---|
| Price | $111.49 | $21.70 |
| Change today | ▲ 0.53% | ▼ 0.30% |
| Market cap | $13.30B | $76.99B |
| Return, 3 months | – | -8.6% |
| Return, year to date | – | -19.6% |
| Return, 1 year | – | -22.4% |
| P/E (TTM) | 2.9 | 7.0 |
| P/B | 0.8 | 0.9 |
| P/E percentile vs own 5y | – | 20th |
| Dividend yield | – | 6.08% |
| Revenue growth (YoY, latest qtr) | – | -1.2% |
| Net profit growth (YoY) | – | -69.0% |
| Gross margin | – | 69.4% |
| Operating margin | – | 14.7% |
| Net margin | – | 9.0% |
| Return on equity | – | 12.0% |
| Analyst target vs. price | +42.7% | +27.6% |
| Analyst buy share | 21% | 33% |
| RSI (14) | – | 31 |
| 30-day volatility | – | 32.0% |
| Max drawdown, 1 year | – | -31.8% |
| Trend read | – | Strong downtrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
